| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34c531b0dce54fb192c75fd1f4f8d473 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2001-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8894c7cd25a0aae38aee5e272b47ab36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6997b7dcb2adac753d7cecfa0276678
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb6ad9e982b326a776fbd77914bc8c85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a686ecaad32ca8f37ef6af80e46de9a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2729e6bcc003174ba269e60a3058124e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aff82574791fce2debf401825c3b67d9 |
| publicationDate |
2003-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-2003156-A3 |
| titleOfInvention |
A method for screening compounds that are useful for the treatment and / or prophylaxis of obesity |
| abstract |
The invention relates to a method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity, whereby the ability of the examined compounds to inhibit de novo lipogenase in mammals and/or humans is determined. Also disclosed is the use of compounds which are capable of inhibiting de novo lipogenase in mammals in the production of medicaments for the treatment and/or phophylaxis of obesity. |
| priorityDate |
2000-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |